Tag: DMC biotechnologies

  • List of Top 6 Biotech Startups In India

    In India, the biotechnology sector is a fast growing industries. The companies under these biotech startups are known for providing better diagnosis, high-quality drugs, and making medicines and MedTec products available at a reasonable price. They aim at getting the best outcome for developing health awareness and upgrading diagnosis facilities for betterment. With the developing technologies, the health care sector is also increasing their quality with the help of these startups in India.

    Amid the pandemic, one of the industries that made a huge growth has to be the biotech industry without a doubt. Apart from the prescribed medication, people were also flocking to get in touch with daily vitamins and other possible nutrients too. This has enabled the biotech industry in India and all over the world take off and flourish. So, let’s get to know what are these biotechnology startups in India in a little bit more detail.

    Top 6 Biotech Startups in India

    1. Biocon
    2. Sea6 Energy
    3. MedGenome
    4. Bharat Biotech
    5. GANIT Labs
    6. Forus Health

    Biocon

    Founded: 1978
    Founder: Kiran Mazumdar Shaw
    Headquarter: Bengaluru

    top biotech startups in India biocon
    Biocon – Biotech Startups in India

    Founded in 1978, Biocon is one of the top biotech startups in India. It started  with a budget of INR 10,000 as a company that used to sell the enzyme papain. The focus of the company changed in the 1990s by the founder, Kiran Mazumdar-Shaw. To make a change, she decided to shift from selling enzymes to selling biopharmaceuticals. Gradually she got enlisted among the richest women in India.

    The annual revenue of Biocon sums upto INR. 4,709 Crores in 2018. By 2020, they have also given access to more than 2.1 million patients through their biosimilars. As of now, their manufactured pharmaceutical ingredients are being sold in more than 120 countries throughout the world.

    Sea6 Energy

    Founded: 2010
    Founder: Nelson Vadassery, Sowmya Balendiran, Sailaja Nori, and Shrikumar suryanarayan
    Headquarter: Bangalore

    top biotech startups in india Sea6 Energy startuptalky
    Sea6 Energy – Biotech Startups in India

    This startup was launched as a way to come up with the solution to the problem of over-consumption of energy in India. Four IIT Madras graduates, Nelson Vadassery, Sailaja Nori, Sowmya Balendiran, and Sayash Kumar came forward with the help of their professor, Shrikumar Suryanarayan. Together, they founded the startup in 2010 and currently it is considered as a top biotech startup in India. The primary aim of the startup is to convert photosynthetic biomass, for instance, plants and algae to fuels – Something that will definitely come in handy in the near future!

    It enables these elements to work into battling against the unending commercial use of energy. It is funded by the Department of Biotechnology and is incubated at the Centre for Cellular and Molecular Platforms (C-Camp). The startup incorporated a few patented techniques in order to facilitate the large-scale cultivation of selected sea plants. The Government of Karnataka has given to the company, the title of “Emerging Company of the Year” in the year 2012.


    List of Top 20 Pharmaceutical Companies in India 2022
    Many Indian Pharmaceutical companies are growing and changing lives globally. Here is the list of the Top Pharmaceutical Companies in India.


    MedGenome

    Founded: 2013
    Founder: Sam Santhosh
    Headquarter: Bangalore

    MedGenome - Biotech Startups in India
    MedGenome – Biotech Startups in India

    Sam Santosh founded the startup, MedGenome, in 2013. It works at providing personalised genetic tests and medicines. It has its working genres scattered for a range of ailments, such as cancer, neurological ailments and diabetes. The largest next-gen sequencing lab in entire southeast Asia, MedGenome has its headquarter located in the USA as well as in bangalore, India.

    The startup crossed a funding of  INR 192 crore in 2017. In the following year, 2018, it bagged the MedTech Breakthrough Award for Biomedical Research. It is leading globally in personalized medicine that provides unique genomic solutions. The areas of their conduct are mainly immuno-oncology, ophthalmology, diabetes, cardiology, and a few other rare diseases.

    Bharat Biotech

    Founded: 1996
    Founder: Krishna Ella
    Headquarter: Hyderabad

    Bharat Biotech - Top Biotech Startups in India
    Bharat Biotech – Top Biotech Startups in India

    Bharat Biotech was founded in the year 1996. The Hyderabad based company was founded by an well known Indian scientist, Krishna Ella. In India, it is the very first pharmaceutical startup that has successfully developed a generic drug.

    It has achieved a huge milestone globally as they developed and received the patent the vaccine Zikavac. This one has been formulated to fight the prevailing Zika virus. It has done indigenous work in developing the covid vaccine – Covaxin. The operating revenues of Bharat Biotech International Limited, generally range over INR 500 Crore.

    GANIT Labs

    Founded: 2010
    Founder: Dr Vinay Panda and Dr Vijaya Chandru
    Headquarter: Bangalore

    Ganit Labs - Top Biotech Startups in India
    Ganit Labs – Top Biotech Startups in India

    The Bangalore based startup, GANIT Labs, has been founded in the year 2010 by Dr Vinay Panda and Dr Vijaya Chandru. The abbreviation GANIT Labs stands for  Genomics Application and Information Technology Labs. As per the latest report on Zoominfo, the company has reached $3.8 million by 2019.

    The primary aims of the company are to study genomes that are related to oral cancer. It also helps in mapping their respective genes. This company has been involved in manufacturing analytical equipment that will effectively analyse and manage genome data on a large scale. It is mainly from the genome sequencing of disease tissues such as cancer.

    Forus Health

    Founded: 2010
    Founder: K. Chandrasekhar
    Headquarter: Bangalore

    Forus Health - Top Biotech Startups in India
    Forus Health – Top Biotech Startups in India

    K. Chandrasekhar, the founder of Forus health, created the startup in 2010. The basic mantras of the company are being claimed as ‘Innovate’, ‘Implement’ and ‘Impact’. The company works to eliminate preventable blindness through an Ophthalmology device, which includes an intelligent pre-screening technique.

    At present, the company operates in 14 other countries other than India. As of the financial year ending on 31 March 2019, operating revenues of Forus Health Private Limited has been displayed between INR 1 Crore – 100 Crore. However, as per the recent information given out by Zoominfo, the revenue has reached $5.7 million by 2020.


    19 Innovative Health Startups in India | List of Top Healthcare Startups
    The hunger for success makes you forget about health. You might be engrossedwith your startup but don’t work yourself to death for a bright entrepreneurialfuture. A wise man once said that health is wealth [/tag/wealth-management/]. The healthcare sector is growing rapidly in the Indian landscap…


    Conclusion

    So with the growth of these biotechnology startups in India, the economy has also gotten a boost. As many of the above companies are actively participating in international transaction, the revenue can also possibly get a favourable development over the year. According to the reports, Indian BioEconomy is dwelling at around $33.6 billion. It has been predicted to grow in size upto $100 billion by 2025. With over 2,600 emerging biotech startups in India, our country has also included 50 BIRAC-supported incubators as well.

    FAQs

    Which is the biggest biotechnology company in India?

    Biocon Limited is the largest Biotechnology Company in India.

    What is the best biotech company in India?

    Some of the best biotechnology companies in India are:

    • Biocon
    • Sea6 Energy
    • MedGenome
    • Bharat Biotech
    • GANIT Labs
    • Forus Health

    Who is owner of Bharat Biotech?

    Dr. Krishna Ella is the Chairman & Managing Director of Bharat Biotech International Limited.

  • Tempus – Company Having World’s Biggest Library of Molecular and Clinical Data

    Company Profile is an initiative by StartupTalky to publish verified information on different startups and organizations. The content in this post has been approved by Tempus.

    Technology is a vast field and in the field of science, technology is getting advanced rapidly. Biotechnology is a department of applied science that uses living organisms and their products to produce various processes. It is a very important part of the industry sector in the economy.

    Tempus is a technology company which has created the world’s biggest library of molecular and clinical data. It is making accurate medicine through the power and the promising nature of data and artificial understanding. Read the Tempus success story below.

    Tempus – Company Highlights

    Company Name Tempus
    Headquarters Chicago, IL, US
    Industry Analytics, Artificial Intelligence, Biotechnology, Healthcare, Medical, and Software
    Founder Eric Lefkofsky
    Founded 2015
    Website tempus.com

    Tempus – About
    Tempus – Founder
    Tempus – Business & Revenue Model
    Tempus – Funding & Investors
    Tempus – Growth & Future
    Tempus – Competitors

    About Tempus

    Tempus – About

    Tempus built an operating system to make information accessible and beneficial for physicians, researchers and patients. The mission and the vision of the company is to change the world in the field of medicine. It enables physicians to deliver personalized attention to everyone’s diagnosis. Tempus also works with partners to encourage development and discovery.

    The company started with the concept of curing patients for a variety of diseases, starting from cancer to depression-like disorders. It is currently also curing Covid patients. The founder of the company had his own personal reasons for founding Tempus.

    ‘My wife was diagnosed with breast cancer about five years ago, and I was amazed how little data was actually used as a part of her therapy, largely because our system makes it hard for doctors to access data when making real-time clinical decisions,’ Lefkofsky said. ‘It became clear to me that I needed to try and tackle this problem, and I founded Tempus soon afterwards.’

    Tempus – Founder

    Eric Lefkofsky, Founder & CEO, Tempus

    Eric Lefkofsky is the founder and the CEO of Tempus. Currently, he is the Chairman and the Co-Founder of Groupon, Lightbank, and Lefkofsky Family Foundation. At Groupon he previously served as the CEO of the company which is an e-commerce marketplace. He is also the founder of MediaBank. He graduated from the University of Michigan.

    Tempus – Business & Revenue Model

    ‘We try to infuse as much data and technology as we can into the diagnosis itself,’ Lefkofsky says.

    The Tempus business model lies in the fact that they do not only focus on cancer but also focuses on other programs which include cardiology, diabetes, mental health or any other infectious or deadly disease. The company offers a service that matches eligible patients to clinical trials. Tempus also licenses de-identified patient data to other players in the oncology industry. Tempus offers a service for the psychiatrists to use a patient’s hereditary information to determine the best treatments for major depressive disorders.

    The main Tempus labs revenue model lies in sequencing the genome of cancer patients’ tumors. It helps the doctors to decide which treatment is more effective for which patient.


    This is How Machine Learning is Revolutionizing the Healthcare Industry
    When we hear AI or machine learning the first thing that comes in our mind is Robots but machine learning is much more complicated than that.


    Tempus – Funding & Investors

    Tempus has raised a total funding of $1.1 Billion. Tempus is funded by 10 investors. It has got 5 lead investors. Baillie Gifford is the most recent investor.

    Date Transaction Name Money Raised Lead Investors
    December 10, 2020 Series G $200 million Google
    December 10, 2020 Debt Financing $250 million
    March 13, 2020 Series G $100 million
    May 30, 2019 Series F $200 million Baillie Gifford
    August 29, 2018 Series E $110 million Baillie Gifford
    March 20, 2018 Series D $80 million T.Rowe Price
    September 25, 2017 Series C $70 million New Enterprise Associates and Eevolution
    April 17, 2017 Series B $30 million
    November 22, 2016 Series B $10 million
    June 20, 2016 Series B $10 million

    Tempus – Growth & Future

    ‘We couldn’t be more thrilled with our progress to date, and we’re honored to be surrounded by world-class investors, collaborators, partners and an incredibly talented team here at Tempus,’ Lefkofsky said in a statement.

    Tempus focuses on the analysis and the gathering of clinical and molecular data. The company considers itself to be the most comprehensive data set in the industry. Tempus believes that it has been only possible with the help of its clinical partners. The company has got relationships with various cancer centers, physicians and health systems. Tempus is growing in such a way that now the company’s technology is affecting 1 in 4 cancer victims in the country.  

    Tempus also recently announced its collaboration with A2 Biotherapeutics to develop a (CDx) companion diagnostic test. It is also looking forward towards the development of more CDx tests for A2’s different clinical development programs.


    Startup Ideas for Medical Practitioners During Pandemic
    Every domain has certain gaps that can be filled only through out-of-the-box solutions. The field of medicine is no exception. Here are some startup ideas for medical practitioners to introspect on and realize their dream of starting their own venture.


    Tempus – Competitors

    The top Tempus competitors COTA, Flatiron Health and Fabric Genomics.

    • COTA is one of the biggest competitors of Tempus. It is headquartered at Boston, MA, USA and was founded in 2011. It works in the Healthcare Technology field.
    • Flatiron Health is perceived as one of the biggest rivals of Tempus. It is headquartered at New York, NY, USA and was founded in 2012.
    • Fabric Genomics is also one of the top competitors of Tempus. It is headquartered at Oakland, California, USA and was founded in 2009.

    Conclusion

    Tempus is making precision medicine a reality through the power and promise of data and artificial intelligence. With the world’s largest library of clinical and molecular data, and an operating system to make that data accessible and useful, we enable physicians to make real-time, data-driven decisions to deliver personalized patient care, and in parallel, facilitate discovery, development, and delivery of optimized therapeutic options for patients through distinctive solution sets.

    FAQs

    What is Tempus?

    Tempus is a technology company that has built the world’s largest library of clinical and molecular data and an operating system to make that information accessible and useful for patients, physicians, and researchers.

    What is Tempus testing?

    The Tempus|TO test compares a patient’s tumor molecular data to a large internal database of annotated tumor data to identify a likely diagnosis that may impact standard of care therapy decisions, clinical trial enrollment, and reimbursement for therapies.

    Who is the founder of Tempus?

    Eric Lefkofsky is the founder & CEO of Tempus.

    When was Tempus founded?

    Tempus was founded in 2015.

    What type of sequencing does Tempus perform?

    Our labs sequence both DNA and RNA from tumor samples as well as matched DNA from normal samples. Sequencing options include a targeted panel of 648 genes (at 500x coverage), whole exome (at 150x coverage), and whole genome (at 30x coverage).

    What is Tempus’ turnaround time for test results?

    Tempus results can be expected 9-14 days after samples are received (both blood and tissue). Sequencing will not begin until all required specimens are received.

    Who can order the Tempus test?

    Clinicians treating patients who suffer from depression, anxiety, or other psychiatric conditions can order a Tempus test.

    Who are the top competitors of Tempus?

    Top competitors of Tempus are:

    • COTA
    • Flatiron Health
    • Fabric Genomics